Point Of Care Diagnostics Market
Point-of-Care Diagnostics Market Forecasts to 2032 – Global Analysis By Product (Glucose Monitoring Kits, Infectious Disease Testing Kits, Pregnancy and Fertility Testing Kits and Other Products), Sample Type, Mode of Testing, Technology, Application, End User and By Geography
According to Stratistics MRC, the Global Point-of-Care Diagnostics Market is accounted for $50.6 billion in 2025 and is expected to reach $75.0 billion by 2032 growing at a CAGR of 5.8% during the forecast period. Point-of-care diagnostics refers to medical testing conducted at or near the site of patient care, providing rapid results without the need for centralized laboratory facilities. These tests are designed for convenience, speed, and accessibility, enabling healthcare providers to make immediate clinical decisions. Common applications include glucose monitoring, infectious disease detection, pregnancy testing, and cardiac markers. POC diagnostics utilize portable devices and easy-to-use kits, often requiring minimal training. They are essential in emergency rooms, clinics, remote areas, and home settings. By reducing turnaround time and improving patient outcomes, point-of-care diagnostics play a vital role in modern, decentralized healthcare delivery.
Market Dynamics:
Driver:
Growing Demand for Rapid and Early Diagnosis
The increasing need for rapid and early diagnosis is a major driver of the point-of-care diagnostics market. These tests enable immediate clinical decisions, especially in emergency settings, rural areas, and home care. With rising cases of infectious and chronic diseases, healthcare providers rely on fast, accurate results to initiate timely treatment. Point-of-care solutions reduce turnaround time, improve patient outcomes, and support decentralized healthcare delivery. Their convenience and speed make them indispensable tools in modern medical practice across global health systems.
Restraint:
Regulatory and Compliance Challenges
Regulatory and compliance challenges pose a significant restraint to the point-of-care diagnostics market. Devices must meet stringent safety, accuracy, and quality standards across different regions, which can delay product approvals and market entry. Navigating complex regulatory frameworks requires substantial investment in testing, documentation, and certification. These hurdles are especially burdensome for startups and small manufacturers. Additionally, evolving regulations around data privacy and diagnostic accuracy further complicate compliance.
Opportunity:
Advancements in technology
Technological advancements offer a powerful opportunity for growth in the market. Innovations in biosensors, microfluidics, and portable analyzers are enhancing test speed, accuracy, and usability. Integration with digital platforms and mobile apps enables real-time data sharing and remote monitoring. These breakthroughs support personalized medicine, telehealth, and decentralized care models. As demand for user-friendly diagnostic tools rises, technology-driven solutions are transforming healthcare delivery. Continued R&D investment will unlock new applications and improve accessibility in both developed and emerging markets.
Threat:
Cost and Reimbursement Issues
Cost and reimbursement issues represent a key threat to the point-of-care diagnostics market. High upfront costs for devices and consumables can deter adoption, especially in low-resource settings. Inconsistent reimbursement policies across regions create uncertainty for providers and manufacturers. Without clear coverage, patients may face out-of-pocket expenses, limiting access to essential diagnostics. These financial barriers hinder market expansion and innovation. Addressing affordability and establishing supportive reimbursement frameworks are critical to ensuring widespread adoption.
Covid-19 Impact:
The COVID-19 pandemic significantly accelerated the adoption of point-of-care diagnostics. The urgent need for rapid testing and decentralized healthcare solutions highlighted the value of portable, easy-to-use diagnostic tools. POC tests played a crucial role in screening, monitoring, and managing outbreaks, especially in remote and high-risk areas. The crisis also spurred innovation in biosensors and mobile diagnostics, reshaping public health strategies. As healthcare systems adapt to post-pandemic realities, point-of-care diagnostics continue to support resilience, preparedness, and patient-centered care across global markets.
The biosensors segment is expected to be the largest during the forecast period
The biosensors segment is expected to account for the largest market share during the forecast period, due to its central role in enabling rapid, accurate point-of-care testing. Biosensors detect biological markers in real time, supporting applications in infectious disease detection, glucose monitoring, and cardiac diagnostics. Their integration into portable devices enhances usability and accessibility. As demand for fast, reliable diagnostics grows, biosensors remain at the forefront of innovation. Continued advancements in sensitivity, miniaturization, and connectivity will further solidify their dominance in the POC diagnostics landscape.
The diabetes segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the diabetes segment is predicted to witness the highest growth rate, due to global rise in diabetes prevalence and the need for continuous glucose monitoring. Point-of-care diagnostics offer convenient, real-time blood sugar testing, empowering patients to manage their condition effectively. Advances in biosensors and wearable devices are enhancing accuracy and ease of use. As healthcare systems prioritize chronic disease management, demand for accessible, personalized diabetes diagnostics continues to surge. This segment’s rapid growth reflects its critical role in preventive and long-term care.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising healthcare demand, expanding middle-class populations, and government initiatives to improve medical access. Countries like China, India, and Japan are investing in decentralized healthcare infrastructure and affordable diagnostic solutions. The region’s strong manufacturing base and increasing adoption of mobile health technologies further support market expansion. Asia Pacific’s dynamic healthcare landscape positions it as a leader in point-of-care innovation and deployment.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced healthcare infrastructure, strong R&D investment, and high demand for rapid diagnostics. The region’s focus on personalized medicine, telehealth, and chronic disease management supports widespread adoption of POC technologies. Regulatory support and reimbursement frameworks also encourage innovation and market entry. With leading manufacturers and early adopters, North America continues to set the pace for technological advancement and market growth in point-of-care diagnostics.
Key players in the market
Some of the key players in Point-of-Care Diagnostics Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Danaher Corporation, Becton, Dickinson and Company (BD), QuidelOrtho Corporation, Thermo Fisher Scientific, bioMérieux SA, Bio-Rad Laboratories, Hologic, Inc., LumiraDx Ltd., SD Biosensor, Nova Biomedical Corporation, Trinity Biotech plc, and Werfen.
Key Developments:
In June 2025, Abbott and MSD Pharmaceuticals (Merck & Co.) have forged a strategic distribution partnership in India for MSD’s oral anti-diabetic drugs Sitagliptin, its fixed-dose combination with metformin and the extended-release version marketed under the names Januvia, Janumet and Janumet XR.
In March 2025, Cadrenal Therapeutics and Abbott have entered collaboration for the “TECH-LVAD” trial to evaluate Tecarfarin in patients using the HeartMate 3 left ventricular assist device (LVAD).
Products Covered:
• Glucose Monitoring Kits
• Infectious Disease Testing Kits
• Pregnancy and Fertility Testing Kits
• Cardiometabolic Monitoring Kits
• Hematology Testing Kits
• Coagulation Testing Kits
• Urinalysis Testing Kits
• Drug-of-Abuse Testing Kits
• Cancer/Tumor Markers Testing Kits
• Other Products
Sample Types Covered:
• Blood
• Urine
• Saliva
• Nasal/Throat Swabs
• Other Sample Types
Modes of Testing Covered:
• Prescription-Based Testing
• Over-the-Counter (OTC) Testing
Technologies Covered:
• Lateral Flow Assays
• Dipsticks
• Microfluidics
• Molecular Diagnostics
• Immunoassays
• Biosensors
• Other Technologies
Applications Covered:
• Infectious Diseases
• Diabetes
• Cardiovascular Diseases
• Cancer
• Pregnancy and Fertility
• Respiratory Diseases
• Other Applications
End Users Covered:
• Hospitals and Critical Care Centers
• Clinics and Physician Offices
• Home Care Settings
• Ambulatory Care Settings
• Diagnostic Laboratories
• Research and Academic Institutes
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Point-of-Care Diagnostics Market, By Product
5.1 Introduction
5.2 Glucose Monitoring Kits
5.3 Infectious Disease Testing Kits
5.4 Pregnancy and Fertility Testing Kits
5.5 Cardiometabolic Monitoring Kits
5.6 Hematology Testing Kits
5.7 Coagulation Testing Kits
5.8 Urinalysis Testing Kits
5.9 Drug-of-Abuse Testing Kits
5.10 Cancer/Tumor Markers Testing Kits
5.11 Other Products
6 Global Point-of-Care Diagnostics Market, By Sample Type
6.1 Introduction
6.2 Blood
6.3 Urine
6.4 Saliva
6.5 Nasal/Throat Swabs
6.6 Other Sample Types
7 Global Point-of-Care Diagnostics Market, By Mode of Testing
7.1 Introduction
7.2 Prescription-Based Testing
7.3 Over-the-Counter (OTC) Testing
8 Global Point-of-Care Diagnostics Market, By Technology
8.1 Introduction
8.2 Lateral Flow Assays
8.3 Dipsticks
8.4 Microfluidics
8.5 Molecular Diagnostics
8.6 Immunoassays
8.7 Biosensors
8.8 Other Technologies
9 Global Point-of-Care Diagnostics Market, By Application
9.1 Introduction
9.2 Infectious Diseases
9.3 Diabetes
9.4 Cardiovascular Diseases
9.5 Cancer
9.6 Pregnancy and Fertility
9.7 Respiratory Diseases
9.8 Other Applications
10 Global Point-of-Care Diagnostics Market, By End User
10.1 Introduction
10.2 Hospitals and Critical Care Centers
10.3 Clinics and Physician Offices
10.4 Home Care Settings
10.5 Ambulatory Care Settings
10.6 Diagnostic Laboratories
10.7 Research and Academic Institutes
11 Global Point-of-Care Diagnostics Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Abbott Laboratories
13.2 F. Hoffmann-La Roche Ltd.
13.3 Siemens Healthineers
13.4 Danaher Corporation
13.5 Becton, Dickinson and Company (BD)
13.6 QuidelOrtho Corporation
13.7 Thermo Fisher Scientific
13.8 bioMérieux SA
13.9 Bio-Rad Laboratories
13.10 Hologic, Inc.
13.11 LumiraDx Ltd.
13.12 SD Biosensor
13.13 Nova Biomedical Corporation
13.14 Trinity Biotech plc
13.15 Werfen
List of Tables
1 Global Point-of-Care Diagnostics Market Outlook, By Region (2024-2032) ($MN)
2 Global Point-of-Care Diagnostics Market Outlook, By Product (2024-2032) ($MN)
3 Global Point-of-Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2024-2032) ($MN)
4 Global Point-of-Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2024-2032) ($MN)
5 Global Point-of-Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2024-2032) ($MN)
6 Global Point-of-Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2024-2032) ($MN)
7 Global Point-of-Care Diagnostics Market Outlook, By Hematology Testing Kits (2024-2032) ($MN)
8 Global Point-of-Care Diagnostics Market Outlook, By Coagulation Testing Kits (2024-2032) ($MN)
9 Global Point-of-Care Diagnostics Market Outlook, By Urinalysis Testing Kits (2024-2032) ($MN)
10 Global Point-of-Care Diagnostics Market Outlook, By Drug-of-Abuse Testing Kits (2024-2032) ($MN)
11 Global Point-of-Care Diagnostics Market Outlook, By Cancer/Tumor Markers Testing Kits (2024-2032) ($MN)
12 Global Point-of-Care Diagnostics Market Outlook, By Other Products (2024-2032) ($MN)
13 Global Point-of-Care Diagnostics Market Outlook, By Sample Type (2024-2032) ($MN)
14 Global Point-of-Care Diagnostics Market Outlook, By Blood (2024-2032) ($MN)
15 Global Point-of-Care Diagnostics Market Outlook, By Urine (2024-2032) ($MN)
16 Global Point-of-Care Diagnostics Market Outlook, By Saliva (2024-2032) ($MN)
17 Global Point-of-Care Diagnostics Market Outlook, By Nasal/Throat Swabs (2024-2032) ($MN)
18 Global Point-of-Care Diagnostics Market Outlook, By Other Sample Types (2024-2032) ($MN)
19 Global Point-of-Care Diagnostics Market Outlook, By Mode of Testing (2024-2032) ($MN)
20 Global Point-of-Care Diagnostics Market Outlook, By Prescription-Based Testing (2024-2032) ($MN)
21 Global Point-of-Care Diagnostics Market Outlook, By Over-the-Counter (OTC) Testing (2024-2032) ($MN)
22 Global Point-of-Care Diagnostics Market Outlook, By Technology (2024-2032) ($MN)
23 Global Point-of-Care Diagnostics Market Outlook, By Lateral Flow Assays (2024-2032) ($MN)
24 Global Point-of-Care Diagnostics Market Outlook, By Dipsticks (2024-2032) ($MN)
25 Global Point-of-Care Diagnostics Market Outlook, By Microfluidics (2024-2032) ($MN)
26 Global Point-of-Care Diagnostics Market Outlook, By Molecular Diagnostics (2024-2032) ($MN)
27 Global Point-of-Care Diagnostics Market Outlook, By Immunoassays (2024-2032) ($MN)
28 Global Point-of-Care Diagnostics Market Outlook, By Biosensors (2024-2032) ($MN)
29 Global Point-of-Care Diagnostics Market Outlook, By Other Technologies (2024-2032) ($MN)
30 Global Point-of-Care Diagnostics Market Outlook, By Application (2024-2032) ($MN)
31 Global Point-of-Care Diagnostics Market Outlook, By Infectious Diseases (2024-2032) ($MN)
32 Global Point-of-Care Diagnostics Market Outlook, By Diabetes (2024-2032) ($MN)
33 Global Point-of-Care Diagnostics Market Outlook, By Cardiovascular Diseases (2024-2032) ($MN)
34 Global Point-of-Care Diagnostics Market Outlook, By Cancer (2024-2032) ($MN)
35 Global Point-of-Care Diagnostics Market Outlook, By Pregnancy and Fertility (2024-2032) ($MN)
36 Global Point-of-Care Diagnostics Market Outlook, By Respiratory Diseases (2024-2032) ($MN)
37 Global Point-of-Care Diagnostics Market Outlook, By Other Applications (2024-2032) ($MN)
38 Global Point-of-Care Diagnostics Market Outlook, By End User (2024-2032) ($MN)
39 Global Point-of-Care Diagnostics Market Outlook, By Hospitals and Critical Care Centers (2024-2032) ($MN)
40 Global Point-of-Care Diagnostics Market Outlook, By Clinics and Physician Offices (2024-2032) ($MN)
41 Global Point-of-Care Diagnostics Market Outlook, By Home Care Settings (2024-2032) ($MN)
42 Global Point-of-Care Diagnostics Market Outlook, By Ambulatory Care Settings (2024-2032) ($MN)
43 Global Point-of-Care Diagnostics Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
44 Global Point-of-Care Diagnostics Market Outlook, By Research and Academic Institutes (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
